Dr Karl Peggs
Haematological oncology (general)
Harley Street at University College Hospital, 5th Floor, Macmillan Cancer Centre, Huntley Street, London WC1E 6AG
Immune reconstitution, management of post-transplant infectious complications, and novel approaches to salvage patients with relapse following transplantation.
Karl Peggs is a reader and honorary consultant in haematology and transplantation at University College London and practises allogeneic, adolescent, autograft and donor-specific transplantation at the attached hospital. He studied at Cambridge, Oxford and UCL and in 2000-2003 established adoptive cellular therapies for cytomegalovirus at UCL. He has also worked at Memorial Sloan-Kettering Cancer Center, New York, in the laboratory of Prof James Allison on novel approaches to immunotherapy in cancer, and continues to research immune reconstitution, management of post-transplant infectious complications, and novel approaches to salvage patients with relapse following transplantation. Dr Peggs is a member of the Leukaemia and Lymphoma Research clinical trials committee, the British Society of Blood and Marrow Transplantation clinical trials committee, a trustee of the Teens Unite charity, and has contributed to several international working parties and guidelines on infectious complications and relapse following stem cell transplantation. He is also chief investigator on four UK Cancer Research Network studies, including two evaluating allogeneic transplantation in Hodgkin lymphoma.